Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00852254 · ClinicalTrials.gov registry record
Validation of Minimally Invasive Ultrasound Indicator Dilution Technique in Critically Ill Children
A clinical trial, sponsored by Transonic Systems.
- Completed
- Registry status
- 9
- Enrollment target
NCT00852254 is a clinical trial that has completed, run by Transonic Systems. The registered enrollment target is 9 participants.
The verdict
NCT00852254 has completed, sponsored by Transonic Systems.
- COMPLETED
- Registry status
- 9 participants
- Enrollment target
Study Summary
A novel method to measure cardiac index based on ultrasound indicator dilution technology (UIDT) has been developed by Transonic Systems Inc. (Ithaca, NY, USA). The method overcomes many of the limitations that have plagued the existing techniques used to measure cardiac index in critically ill children. In the proposed investigation, the investigators hope to validate a novel application of an existing technology in critically ill infants and children. The primary aim of this study is to determine the accuracy of cardiac index measured by UIDT when compared to the gold-standard Fick technique. The primary hypothesis is that the average of three consecutive measurements of cardiac index by UIDT will be accurate when compared to the Fick technique. Secondary aims will be to determine the precision of the measurement, the feasibility of the technique with regards to time required and any complications encountered. An exploratory secondary aim of this study is to determine whether central blood volume (CBV) derived from indicator transit time (ITT) correlates with central venous pressure (CVP) and echocardiography derived measures of preload.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2008-06 |
| Est. Completion | 2011-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00852254
The ClinicalTrials.gov registry entry for NCT00852254 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Transonic Systems, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00852254 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00852254 about?
NCT00852254 is a clinical study titled "Validation of Minimally Invasive Ultrasound Indicator Dilution Technique in Critically Ill Children". A novel method to measure cardiac index based on ultrasound indicator dilution technology (UIDT) has been developed by Transonic Systems Inc. (Ithaca, NY, USA). The method overcomes many of the limitations that have plagued the existing techniques used to measure cardiac index in critically ill chil...
What is the current status of trial NCT00852254?
This trial is currently completed. The enrollment target is 9 participants. The study started on 2008-06. Estimated completion is 2011-05.
Who is sponsoring clinical trial NCT00852254?
This trial is sponsored by Transonic Systems, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.